Therapies supporting the treatment of neurological conditions, developed to international quality standards.
Our Portfolio
Products in this therapeutic area
3 products manufactured or supplied by Sudair Pharma. Product information is intended for healthcare professionals; please refer to the approved prescribing information.
Parinso
Parinso® – Lacosamide Film-Coated Tablets (50, 100, 150 & 200 mg) Indicated for: Certain types of epilepsy in adults and children ≥4 years.
Eligon® – Fingolimod 0.5 mg Capsules Indicated for: Relapsing-remitting multiple sclerosis (RRMS) in adults and patients ≥10 years with treatment failure or rapidly evolving severe MS.
Manufactured to international standards
Every product in this portfolio is made under cGMP, in facilities aligned to SFDA, PIC/S, ISO and WHO expectations.
Enquiries
Looking for product information?
Our medical and regulatory teams can support healthcare professionals with product enquiries and prescribing information.